Marc Riffet

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Centre National de la Recherche Scientifique(Current)

Inserm

Centre Hospitalier Universitaire de Caen Normandie

Université de Caen Normandie

Normandie Université

Marc Riffet is an author at Centre National de la Recherche Scientifique specializing in neoadjuvant therapy integration, lung cancer resection, and medicine.

Publications per year

2017–2023

Publications

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers

Marc Riffet, Yassine Eid, Maxime Faisant et al. · Cancers · 2021 · 34 citations · Full text

Medicine, Genetics, Oncology +17

Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer

Delphine Dumont, Pascal Dô, D. Lerouge et al. · American Journal of Case Reports · 2017 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding

Marc Riffet, Benoît Dupont, Maxime Faisant et al. · International Journal of Molecular Sciences · 2023 · 12 citations · Full text

Medicine, Oncology, Pathology +17

1–3 of 3